Easywell Biomedicals Statistics

Total Valuation

Easywell Biomedicals has a market cap or net worth of TWD 7.36 billion. The enterprise value is 7.39 billion.

Market Cap	7.36B
Enterprise Value	7.39B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Easywell Biomedicals has 121.87 million shares outstanding. The number of shares has increased by 3.63% in one year.

Current Share Class	n/a
Shares Outstanding	121.87M
Shares Change (YoY)	+3.63%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.91%
Owned by Institutions (%)	0.03%
Float	55.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.80
PB Ratio	10.08
P/TBV Ratio	12.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-61.17
EV / Sales	15.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-44.64

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.61.

Current Ratio	2.91
Quick Ratio	1.92
Debt / Equity	0.61
Debt / EBITDA	n/a
Debt / FCF	-2.74
Interest Coverage	-5.46

Financial Efficiency

Return on equity (ROE) is -17.79% and return on invested capital (ROIC) is -6.09%.

Return on Equity (ROE)	-17.79%
Return on Assets (ROA)	-5.33%
Return on Capital (ROIC)	-6.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.37
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.09% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+44.09%
50-Day Moving Average	78.74
200-Day Moving Average	110.94
Relative Strength Index (RSI)	38.86
Average Volume (20 Days)	546,119

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Easywell Biomedicals had revenue of TWD 483.81 million and -120.87 million in losses. Loss per share was -1.02.

Revenue	483.81M
Gross Profit	279.11M
Operating Income	-110.58M
Pretax Income	-125.10M
Net Income	-120.87M
EBITDA	-61.24M
EBIT	-110.58M
Loss Per Share	-1.02

Full Income Statement

Balance Sheet

The company has 438.08 million in cash and 453.68 million in debt, giving a net cash position of -15.60 million or -0.13 per share.

Cash & Cash Equivalents	438.08M
Total Debt	453.68M
Net Cash	-15.60M
Net Cash Per Share	-0.13
Equity (Book Value)	747.30M
Book Value Per Share	5.99
Working Capital	481.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -153.97 million and capital expenditures -11.65 million, giving a free cash flow of -165.62 million.

Operating Cash Flow	-153.97M
Capital Expenditures	-11.65M
Free Cash Flow	-165.62M
FCF Per Share	-1.36

Full Cash Flow Statement

Margins

Gross margin is 57.69%, with operating and profit margins of -22.86% and -24.98%.

Gross Margin	57.69%
Operating Margin	-22.86%
Pretax Margin	-25.86%
Profit Margin	-24.98%
EBITDA Margin	-12.66%
EBIT Margin	-22.86%
FCF Margin	n/a

Dividends & Yields

Easywell Biomedicals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.63%
Shareholder Yield	-3.63%
Earnings Yield	-1.69%
FCF Yield	-2.25%

Stock Splits

The last stock split was on September 30, 2022. It was a reverse split with a ratio of 0.7.

Last Split Date	Sep 30, 2022
Split Type	Reverse
Split Ratio	0.7

Scores

Easywell Biomedicals has an Altman Z-Score of 9.28.

Altman Z-Score	9.28
Piotroski F-Score	n/a